drugset / Trial / NCT01934335
Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this project is to examine whether treatment with vandetanib has an effect on the tumor cells in breast cancer by examining tissue markers.
Timeline
- Start
- 2013-10
- Primary completion
- 2018-12-21
- Completion
- 2018-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vandetanib | Small molecule | 300 mg | Oral |